Article
Recombinant IgG1 Fc hexamers block cytotoxicity and pathological changes in experimental in vitro and rat models of neuromyelitis optica.
Neuropharmacology - 1 May 2018
Tradtrantip Lukmanee, Felix Christian M, Spirig Rolf, Morelli Adriana Baz, Verkman A S
Abstract excerpt
Intravenous human immunoglobulin G (IVIG) may have therapeutic benefit in neuromyelitis optica spectrum disorders (herein called NMO), in part because of the anti-inflammatory properties of the IgG Fc region. Here, we evaluated recombinant Fc hexamers consisting of the IgM μ-tailpiece fused with the Fc region of human IgG1. In vitro, the Fc hexamers prevented cytotoxicity in aquaporin-4 (AQP4) expressing cells...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
